MouSensor Secures $3.3M Seed Funding to Digitize Smell with Proprietary Olfactory Chip Technology

2018Year9Month26Day,VCBeat (WeChat ID:VCbeat) learned from ，Biotechnology CompanyMouSensorCompleted.330USD 10,000 in seed funding. Previously,MouSensorPreviously at2017year, received the Small Business Innovation Research (SBIR) grant from the U.S. National Science Foundation (NSF SBIR）22500USD funding.

This round of financing was led byimec.xpandandAlexandria Venture InvestmentsLead investor, with participating investors includingNew York Ventures and Elma HawkinsPh.D.MouSensorThis round of funding will be used to develop an active chip capable of detecting, identifying, and digitizing every type of odor. Whether it is the fragrance in a perfumer’s bottle or disease-related odors associated with conditions such as Parkinson’s disease, they can all be detected by this chip and digitally recorded in its olfactory database. This technology has been granted exclusive global licensing rights.

MouSensor's core technology is from Hunter College of the City University of New YorkFeinsteinDeveloped by the Neurogenetics Laboratory, the company's founding team includes: Co-founder andCEO Charlotte D'HulstPh.D., Co-founder andCSO Paul FeinsteinPh.D. (a world-renowned expert in the molecular biology of olfaction),MouSensor Europe BVBAManaging DirectorElke GietsPh.D.MouSensorofCEO Charlotte D'Hulstby the Belgian newspaper “De Tijd》Nominated for the Future50One of the Flemish innovators.

MouSensorWith Nano-Electronics Innovatorsimec  (Leuven, Belgium)Collaboration, willMouSensor Biologyintegrated with silicon chip technology. This collaborative R&D effort has recently receivedFlanders Innovation & Entrepreneurship (VLAIO)Provided120USD 10,000 in funding.MouSensorA subsidiary has been established in Belgium to facilitate collaboration withimeccooperation, and to advance its own chip technology development.

MouSensorThis technology provides an objective method for measuring odors, holding significant commercial value in the fragrance and flavor industry. Currently, the company’s R&D pipeline for new aromatic compounds is valued at up to15hundred million U.S. dollars. In addition,MouSensorchip technology can encode odors associated with certain diseases. Currently,MouSensorObtainedThe Michael J. Fox Foundationprovided25$10,000 in funding to support research on Parkinson's disease. The study was based on a “Super Smellers” Report Sparks Interest: The article states that these individuals can detect a specific odor associated with Parkinson’s disease patients prior to the onset of major motor symptoms.

MouSensorThe Company's Chief Scientific OfficerPaul FeinsteinThe professor stated, “The most mysterious human sense is olfaction, andMouSensorA tool capable of interpreting this sensory input has been developed, resolving a long-standing challenge in the field of olfaction30years of issues. Human evolution has endowed us with the sense of smell, which we have leveraged to design “Olfactory chip,” thereby assigning a unique identifier to every scent on Earth.

MouSensorThe Scientific Advisory Committee is composed of world-leading experts in the molecular biology of olfaction, including: Professor of Neuroscience and Neurosurgery at Yale UniversityCharles GreerPh.D., Professor of Molecular Biology at Johns Hopkins University, and Doctorate in GeneticsRandall Reed , President of the University of Florida,Jeffrey MartensPh.D.,Thomas H. MarenProfessor,Michael J. Fox Foundation for Parkinson's Researchof the frontChief Scientific AdvisorEm. Eugene JohnsonProfessor,Board Members,Procter & Gamble Former R&D DirectorSteve Hicks。

AboutMouSensor

MouSensorEstablished in2016year, headquartered in New York, is an early-stage biotechnology startup and also the City University of New York (CUNY) branch, or a full-service startup platform companyAlexandria LaunchLabsmembers.MouSensorWe are designing an active chip to detect, identify, and digitize every scent on Earth, thereby establishing the first-ever digital scent database.